Correlation Between Expression of Estrogen Receptor Beta and Endocrine Therapy Result and Prognosis in Breast Cancer Patients

徐彬,方志沂,刘君,李强
DOI: https://doi.org/10.3969/j.issn.1001-5930.2005.04.019
2005-01-01
Abstract:Objective To find out the correlation between the expression of ERβ and the endocrine therapy result and prognosis in breast cancer patients.Methods 97 cases of primary breast cancer treated with operation were collected.Retrospective cohort study was used.ERα and ERβ were detected by S-P immunohistochemical technique.The patients were divided into positive and negative group including 61 and 36 cases respectively according to ERβ expression.The data was analyzed combining with clinicopathological characters and prognosis using Kaplan-Meier method,Log-rank test and Cox regression.Results In univariant analysis the 3-year and 5-year overall and disease free survival rates were 93.44%,93.44% and 83.61%,81.97% respectively in ERβ positive group;61.11%,55.56% and 27.78%,27.78% respectively in ERβ negative group.The differences were all significant(P0.01).In multivariants analysis ERβ,involved axillary lymph node number,menstrual state and ERα were the independent factors which might affect overall survival rates and disease free survival rates(P0.05 or 0.01).For ERβ positive patients,the 5-year overall and disease free survival rates in endocrine therapy group were 91.18% and 88.24% respectively superior to those in non-endocrine therapy group(74.07% and 74.07%).Conclusion ERβ is of value to assess the breast cancer patient's prognosis.It is an independent factor.Endocrine therapy is effective in ERβ positive breast cancer patients.
What problem does this paper attempt to address?